Private Equity Health Care Acquisitions – June 2024

Report an error

Summary

AI-generated

This summary is written by a language model reading the source document. It is not the publisher's words and is not a substitute for the original.

Learn more about AI enrichment

In June 2024, private equity activity in healthcare included 12 buyouts, 34 add-on acquisitions, and 27 growth/expansion investments. The report highlights a trend of consolidation in revenue cycle management (RCM) and the rapid expansion of clinical research sites through roll-up strategies.

Key insights

AI-generated

These insights are written by a language model reading the source document. They are not the publisher's words and are not a substitute for the original.

Learn more about AI enrichment
  • Private equity activity in healthcare for June 2024 consisted of 12 buyouts, 34 add-on acquisitions, and 27 growth/expansion investments.
  • There is significant private equity interest in revenue cycle management (RCM), driven by the consolidation of medical and dental service organizations into large platform companies, which increases the demand for accounts receivable and revenue management services.
  • The global revenue cycle management market was valued at $96.8 billion in 2022 and is projected to grow to $238.4 billion by 2030, with the U.S. holding the largest revenue share in North America.
  • Vista Equity Partners executed a public-to-private transaction to acquire Model N, a revenue management company for medical technology and pharmaceutical firms, for approximately $1.25 billion.
  • Pinnacle Clinical Research, owned by LongueVue Capital, expanded its footprint to 12 locations in June 2024 by acquiring five additional sites, shifting its research focus from liver diseases to include Alzheimer’s Disease and the central nervous system.
  • The clinical trial industry is a target for private equity roll-up strategies due to its high fragmentation, allowing firms to consolidate sites and resell the larger entity for profit, though this strategy has been linked to staffing issues and site closures.
  • Summit Clinical Research, acquired by LongueVue Capital via a leveraged buyout in 2022, operates over 100 locations across seven countries, including the U.S., Europe, South America, and the Caribbean.

Cite the original document

APA
Private Equity Stakeholder Project (2024). Private Equity Health Care Acquisitions – June 2024. https://pestakeholder.org/news/private-equity-health-care-acquisitions-june-2024/
Chicago
Private Equity Stakeholder Project. Private Equity Health Care Acquisitions – June 2024. 2024. https://pestakeholder.org/news/private-equity-health-care-acquisitions-june-2024/.
Wikipedia
{{cite report |author=Private Equity Stakeholder Project |title=Private Equity Health Care Acquisitions – June 2024 |date=16 July 2024 |url=https://pestakeholder.org/news/private-equity-health-care-acquisitions-june-2024/ |access-date=23 October 2026 |via=Climate Insights Directory}}
BibTeX
@techreport{privateequitystakeholderproject2024private, author = {{Private Equity Stakeholder Project}}, title = {{Private Equity Health Care Acquisitions – June 2024}}, institution = {Private Equity Stakeholder Project}, year = {2024}, month = jul, url = {https://pestakeholder.org/news/private-equity-health-care-acquisitions-june-2024/}, urldate = {2026-10-23}, note = {Indexed by Climate Insights Directory} }

Full text

Collected · Record updated